What Oral Health Evidence Means for Nicotine Pouch Regulation

As nicotine pouches become more widely available in global markets, questions about their long-term health effects continue to shape regulatory discussions. Among the most frequently debated issues is oral health. Reports of gum irritation, white lesions, gingival recession, and other local effects have prompted concerns from dental professionals, healthcare providers, and regulators, while supporters of tobacco harm reduction point to the absence of combustion and substantially lower exposure to many toxicants found in cigarette smoke.

These perspectives need not be mutually exclusive.

For GINN, the emerging evidence presents a nuanced picture. Nicotine pouches are not risk-free, and oral health concerns deserve careful attention. At the same time, the current evidence base remains limited, particularly regarding long-term outcomes such as periodontal disease progression and oral cancer risk. The challenge for policymakers is not whether to acknowledge these risks, but how to manage them through evidence-based regulation, robust product standards, continued scientific evaluation, and informed clinical practice.

What the Current Evidence Shows

A growing body of published research has identified several local oral effects associated with nicotine pouch use. A 2024 systematic review, case series, and narrative reviews have reported temporary gum irritation, soreness at the placement site, dry mouth, white mucosal lesions, gingival recession, and other localised oral changes among some users. Histopathological examinations have identified findings including hyperkeratosis, epithelial thickening, oedema, and chronic inflammatory infiltrates at common placement sites.

Researchers suggest that these effects may be influenced by several factors, including nicotine concentration, product pH, flavouring ingredients, duration of use, frequency of placement, and individual susceptibility.

These findings should not be dismissed. They reinforce the importance of ensuring that nicotine pouches are manufactured to high product standards and that consumers receive accurate information about appropriate use and the possibility of local irritation.

Dental professionals also have an important role to play. Reviews published for the dental community encourage clinicians to routinely ask patients about nicotine pouch use, recognise pouch-related mucosal changes during oral examinations, differentiate these lesions from other oral conditions, and provide appropriate clinical advice and follow-up where necessary.

At the same time, it is essential to distinguish between local oral effects and the broader health risks associated with combustible tobacco. Current evidence has not demonstrated that nicotine pouches expose users to the thousands of combustion-derived toxic chemicals responsible for most smoking-related disease and oral cancer. This distinction remains fundamental to evidence-based discussions of relative risk.

What We Still Do Not Know

Despite increasing scientific interest, the evidence base remains relatively limited.

Many published studies involve small sample sizes, short follow-up periods, observational designs, or case reports, making it difficult to draw definitive conclusions about long-term oral health outcomes. Researchers continue to identify important evidence gaps regarding prolonged exposure, cumulative effects, differences between formulations, nicotine strengths, flavouring agents, product pH, periodontal disease progression, and potential cancer risk.

Several recent reviews explicitly conclude that further high-quality longitudinal studies are needed before firm conclusions can be drawn regarding the long-term oral health implications of nicotine pouch use.

As with many emerging nicotine products, the absence of long-term evidence should not be interpreted either as proof of safety or proof of serious harm. Instead, it highlights the need for continued independent research, consistent surveillance, adverse-event reporting, and ongoing scientific evaluation.

Recognising uncertainty is not a weakness in science—it is an essential component of evidence-based policymaking.

Lower Risk Does Not Mean Risk-Free

Public discussion often falls into one of two extremes.

Some portray nicotine pouches as essentially harmless, while others suggest they present risks equivalent to combustible cigarettes.

Neither position accurately reflects the available evidence.

Nicotine remains an addictive substance and is not appropriate for children, adolescents, pregnant women, or individuals who do not already use nicotine products. Local oral irritation, gingival recession, and persistent mucosal lesions should be taken seriously, and individuals experiencing ongoing symptoms should seek advice from a dentist or other qualified healthcare professional.

Published reviews suggest that non-combustible nicotine products may have fewer detrimental oral effects than smoking, yet oral health outcomes among users may still be poorer than among non-users. Effective public health communication should therefore explain both the known risks and the current limitations of the evidence without exaggeration or minimisation.

Product Standards Can Reduce Risk

The oral health concerns identified by published research also point toward practical regulatory solutions.

Rather than relying primarily on bans, regulators can establish product standards that directly address the factors most likely to influence product safety and quality.

These standards may include limits on nicotine concentration, controls on product pH, restrictions on potentially irritating flavouring ingredients, contaminant testing for heavy metals and tobacco-specific nitrosamines, good manufacturing practice requirements, ingredient disclosure, accurate labelling, and robust post-market surveillance.

Such measures improve consistency across products while providing regulators with mechanisms to identify and remove products that fail to meet established safety requirements.

This approach focuses on managing identified risks rather than assuming all products within a category present the same level of concern.

Supporting Dental Professionals

Dentists, dental hygienists, and other oral healthcare professionals are central to identifying and managing pouch-related oral health effects.

Routine oral examinations provide opportunities to detect early signs of irritation, monitor lesions over time, educate patients on correct product placement and duration of use, reinforce good oral hygiene practices, and encourage patients to report persistent or worsening symptoms.

Clinical reviews have also highlighted the importance of including nicotine pouch use within routine patient histories, allowing clinicians to distinguish pouch-related lesions from other oral conditions that may require different management.

Importantly, conversations between dental professionals and patients should remain evidence-based.

Patients benefit most from balanced discussions that explain what is currently known, openly acknowledge scientific uncertainty, and avoid overstating either the benefits or the risks of emerging nicotine products.

As new evidence becomes available, clinical guidance should continue to evolve alongside the science.

Better Evidence for Better Policy

Scientific uncertainty should encourage better research, not policy paralysis.

Governments, regulators, manufacturers, academic institutions, and healthcare professionals all have an interest in strengthening the evidence base through independent longitudinal studies, standardised research methodologies, adverse-event registries, and international collaboration.

Better evidence will improve regulatory decision-making, strengthen clinical guidance, support consumer understanding, and allow product standards to evolve in line with emerging science.

Well-designed regulation should therefore remain adaptable, allowing policies to respond to new evidence as it becomes available.

Looking Ahead

The growing body of research on nicotine pouches and oral health reinforces an important public health principle: identifying risk should lead to better risk management.

Current evidence indicates that nicotine pouches can cause local oral effects that warrant continued monitoring, consumer education, and appropriate clinical attention. At the same time, the available evidence does not support treating every nicotine product as presenting identical risks to combustible tobacco.

For GINN, this underscores the importance of evidence-based, risk-proportionate regulation. Robust product standards, transparent manufacturing requirements, ongoing scientific evaluation, strong consumer protections, and engagement with dental professionals provide regulators with practical tools to address emerging risks while maintaining appropriate oversight.

As the science continues to develop, policymakers should resist both complacency and overreaction. The strongest regulatory frameworks will be those that recognise uncertainty, respond to new evidence, protect consumers, and support better public health outcomes over time.

References

1. Azzopardi D, et al. What is the impact of nicotine pouches on oral health? British Dental Journal. 2024. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC11297755/
2. Yingst JM, et al. Oral health risks in adults who use electronic nicotine delivery systems and oral nicotine pouches: A critical review of the literature and qualitative synthesis of the available evidence. Journal of Evidence-Based Dental Practice. 2024. Available at: https://pubmed.ncbi.nlm.nih.gov/39736680/
3. Kallischnigg G, et al. Oral mucosal changes caused by nicotine pouches: Case series. Diagnostic Pathology. 2024;19. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC11412064/
4. Roseman University College of Dental Medicine. Emerging evidence on nicotine pouches and oral health. Research Symposium Poster. Available at: https://ecommons.roseman.edu/cgi/viewcontent.cgi?article=1642&context=researchsymposium
5. McNeill A, et al. Nicotine pouches, oral cancer and tobacco harm reduction. Journal of Oral Pathology & Medicine. 2025. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC12926464/